Prenetics CFO Holds Steady Shares, RSUs Set for 2026 Dilution | Stock Slips 3.7%
Insightful analysis of Prenetics Global’s insider holdings, RSU‑driven dilution, and market dynamics reveals how CFO stakes and regulatory wins could shape its growth in genetic testing.
3 minutes to read